Inside India’s biggest NBFC IPO yet | The Daily Brief #324

Video Description

In today's episode of The Daily Brief, we cover 2 major stories shaping the Indian economy and global markets: 1. Tata Capital’s Mega IPO and India’s Credit Story We’ll look into Tata Capital’s upcoming ₹15,500 crore IPO — India’s largest ever by an NBFC — and why its unlisted shares have crashed ahead of listing. The story explores how Tata Capital fits into India’s fast-growing credit landscape, how NBFCs are driving financial inclusion, and what risks could shape the company’s future amid rising competition and tighter regulations. 2. India’s Healthcare Workforce — Growth and Gaps We’ll talk about a new World Bank study revealing how India’s healthcare workforce has expanded sharply but remains deeply uneven. The report uncovers major shortages in rural areas, rising private sector dominance, gender pay gaps, and migration trends — and highlights how fixing training, job quality, and workforce distribution will be key to achieving universal healthcare. Timestamps: 00:00 Intro 00:29 Tata Capital: Beyond the IPO buzz 10:08 India's health labor market 25:17 Tidbits Get smarter every day with our daily newsletter. Subscribe here: https://thedailybrief.zerodha.com/ Checkout Markets By Zeodha's Reddit here: https://www.reddit.com/r/marketsbyzerodha/ Checkout The Chatter here: https://thechatterbyzerodha.substack.com/ Check out our latest newsletter "Aftermarket Report" here: https://aftermarketreport.substack.com/ Every day, each team member shares something they've learned, not limited to finance. It's our way of trying to be a little less dumb every day. Check it out here: https://onethingwelearned.today/ Listen to this episode on your preferred podcast platform: Spotify: https://open.spotify.com/show/2SJiLdv5LdxN2y2TKzJcdn Apple Podcasts: https://podcasts.apple.com/in/podcast/the-daily-brief/id1754694834 Disclaimer: Some image(s) may have been created using Al, no copyright infringement is intended. Note: This content is for informational purposes only. None of the stocks, brands or products mentioned are recommendations or endorsements.